NorthRock Partners LLC Has $585,000 Holdings in Agilent Technologies, Inc. $A

NorthRock Partners LLC boosted its holdings in Agilent Technologies, Inc. (NYSE:A) by 64.6% during the 2nd quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 4,953 shares of the medical research company’s stock after acquiring an additional 1,944 shares during the quarter. NorthRock Partners LLC’s holdings in Agilent Technologies were worth $585,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Stone House Investment Management LLC purchased a new stake in shares of Agilent Technologies in the first quarter worth approximately $30,000. Ransom Advisory Ltd bought a new stake in Agilent Technologies during the first quarter worth $32,000. Central Pacific Bank Trust Division purchased a new stake in Agilent Technologies in the 2nd quarter valued at $33,000. Zions Bancorporation National Association UT bought a new position in Agilent Technologies during the 1st quarter valued at $38,000. Finally, Costello Asset Management INC purchased a new position in Agilent Technologies during the 1st quarter worth $47,000.

Wall Street Analysts Forecast Growth

A has been the subject of several analyst reports. Weiss Ratings reiterated a “hold (c)” rating on shares of Agilent Technologies in a report on Wednesday, October 8th. JPMorgan Chase & Co. increased their price objective on shares of Agilent Technologies from $155.00 to $165.00 and gave the company an “overweight” rating in a research note on Thursday, October 9th. Wall Street Zen raised shares of Agilent Technologies from a “hold” rating to a “buy” rating in a research report on Friday, October 3rd. Rothschild Redb raised Agilent Technologies to a “strong-buy” rating in a report on Wednesday, October 8th. Finally, Rothschild & Co Redburn assumed coverage on Agilent Technologies in a report on Wednesday, October 8th. They set a “buy” rating and a $165.00 price target on the stock. One equities research analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating and six have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $149.62.

Agilent Technologies Trading Up 0.8%

Shares of A stock opened at $139.14 on Thursday. The company has a quick ratio of 1.71, a current ratio of 2.25 and a debt-to-equity ratio of 0.53. The firm has a market cap of $39.45 billion, a P/E ratio of 32.66, a PEG ratio of 4.51 and a beta of 1.26. The company has a 50 day moving average of $126.49 and a 200-day moving average of $117.46. Agilent Technologies, Inc. has a 12-month low of $96.43 and a 12-month high of $153.84.

Agilent Technologies (NYSE:A) last posted its quarterly earnings data on Wednesday, August 27th. The medical research company reported $1.37 EPS for the quarter, meeting the consensus estimate of $1.37. Agilent Technologies had a return on equity of 25.51% and a net margin of 17.97%.The business had revenue of $1.74 billion for the quarter, compared to the consensus estimate of $1.67 billion. During the same quarter in the prior year, the business earned $1.32 earnings per share. Agilent Technologies’s revenue for the quarter was up 10.1% on a year-over-year basis. Agilent Technologies has set its FY 2025 guidance at 5.560-5.590 EPS. Q4 2025 guidance at 1.570-1.600 EPS. Sell-side analysts anticipate that Agilent Technologies, Inc. will post 5.58 earnings per share for the current year.

Agilent Technologies Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, October 22nd. Investors of record on Tuesday, September 30th will be issued a $0.248 dividend. The ex-dividend date of this dividend is Tuesday, September 30th. This represents a $0.99 annualized dividend and a yield of 0.7%. Agilent Technologies’s dividend payout ratio (DPR) is 23.24%.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.